ClinConnect ClinConnect Logo
Search / Trial NCT04335903

The Turkish Version of the Vividness of Visual Imagery Questionnaire-2

Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Apr 3, 2020

Trial Information

Current as of June 19, 2025

Completed

Keywords

Imagination Motor Imagery Body Image Kinesthesis

ClinConnect Summary

The Vividness of Visual Imagery Questionnaire-2 (VMIQ-2) was originally developed in English to determine the vividness of visual imagery. The purpose of this study is to translate and cross-culturally adapt the VMIQ-2 instrument into Turkish and investigate its psychometric properties. One hundred fifty healthy participants will be included. For cross-cultural adaptation, two bi-lingual translators will use the back-translation procedure. Within a 5-to-7-day period after the first assessment, the participants will complete the Turkish version of VMIQ (VMIQ-2-T) to evaluate test-retest reli...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age over 18 years old
  • ability to read and write in Turkish
  • no pathology in visual ability and hearing
  • able to follow simple instructions
  • Exclusion Criteria:
  • having a chronic disease
  • severe musculoskeletal, neurological or cardiovascular disorders that limit mobility
  • having any cognitive problem

About Istanbul University Cerrahpasa

Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.

Locations

Istanbul, Bakırkoy, Turkey

Patients applied

0 patients applied

Trial Officials

Tansu Birinci, MSc

Principal Investigator

Istanbul University - Cerrahpasa

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials